Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05992623 · ClinicalTrials.gov registry record · NA
Clinical Trial Comparing Devices Used for Cardioversion of Atrial Fibrillation
A NA study of Atrial Fibrillation, sponsored by Inova Health Care Services.
- Completed
- Registry status
- NA
- Development phase
- 546
- Enrollment target
- 1
- Study location
NCT05992623 is a NA study of Atrial Fibrillation that has completed, run by Inova Health Care Services. The registered enrollment target is 546 participants, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05992623, a NA study of Atrial Fibrillation, has completed, sponsored by Inova Health Care Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 546 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this single center, investigator initiated, open label prospective randomized controlled trial is to compare the efficacy of a single 200J RBW shock and a single 360J BTE shock. The secondary objective of the study is to compare the frequency of adverse events after one or two 200J RBW or 360J BTE shocks
Conditions Studied
Interventions
- DEVICE Zoll external defibrillator
- DEVICE Lifepak external defibrillator
Study Locations (1)
Virginia
- Inova Health System - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2023-07-21 |
| Est. Completion | 2024-12-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05992623
The ClinicalTrials.gov registry entry for NCT05992623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 546 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (82% lower). The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Zoll external defibrillator is the first listed.
NCT05992623 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT05992623 about?
NCT05992623 is a clinical study titled "Clinical Trial Comparing Devices Used for Cardioversion of Atrial Fibrillation". The goal of this single center, investigator initiated, open label prospective randomized controlled trial is to compare the efficacy of a single 200J RBW shock and a single 360J BTE shock. The secondary objective of the study is to compare the frequency of adverse events after one or two 200J RBW o...
What is the current status of trial NCT05992623?
This trial is currently completed. It is a NA study. The enrollment target is 546 participants. The study started on 2023-07-21. Estimated completion is 2024-12-11.
What conditions does trial NCT05992623 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT05992623?
The interventions under investigation include: Zoll external defibrillator (DEVICE), Lifepak external defibrillator (DEVICE).
Who is sponsoring clinical trial NCT05992623?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05992623 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.